Use of Echocardiography in Patients with Hypertrophic Cardiomyopathy: Clinical Implications of Massive Hypertrophy

Journal of the American Society of Echocardiography

Volumn 19, Issue 6, 2006, Pages 788-795

  Sorajja, Paul ^a   Nishimura, Rick A ^a   Ommen, Steve R ^a   Ackerman, Michael J ^a   Tajik, A Jamil ^a   Gersh, Bernard J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DATA ANALYSIS; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; GROUPS BY AGE; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; SUDDEN DEATH; SURVIVAL;

ADULT; AGED; CARDIOMEGALY; CARDIOMYOPATHY, HYPERTROPHIC; COMORBIDITY; DEATH, SUDDEN, CARDIAC; ECHOCARDIOGRAPHY; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 33744514600     PISSN: 08947317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.echo.2006.01.005     Document Type: Article

References (29)

1. Maron B.J., Gardin J.M., Flack J.M., Gidding S.S., Kurosaki T.T., and Bild D.E. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. echocardiographic analysis of 4111 subjects in the CARDIA study. Circulation 92 (1995) 785-789
2. McKenna W.J. Report of the World Health Organization/International Society and Federation of Cardiology task force on the definition and classification of cardiomyopathies. Circulation 93 (1996) 841-842 (corresponding author)
3. Maron B.J., and Epstein S.E. Hypertrophic cardiomyopathy. a discussion of nomenclature. Am J Cardiol 43 (1979) 1242-1244
4. Shapiro L.M., and McKenna W.J. Distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. a two-dimensional echocardiographic study. J Am Coll Cardiol 2 (1983) 437-444
5. Maron B. Hypertrophic cardiomyopathy. a systematic review. JAMA 287 (2002) 1308-1320
6. Spirito P., Seidman C.E., McKenna W.J., and Maron B.J. Management of hypertrophic cardiomyopathy. N Engl J Med 336 (1997) 775-785
7. Maron B.J., Shen W.K., Link M.S., Epstein A.E., Almquist A.K., Daubert J.P., et al. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med 342 (2000) 365-373
8. Spirito P., Bellone P., Harris K.M., Bernabó P., Bruzzi P., and Maron B.J. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med 342 (2000) 1778-1785
9. Elliott P.M., Blanes J.R.G., Mahon N.G., Poloniecki J.D., and McKenna W.J. Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy. Lancet 357 (2001) 420-424
10. Olivotto I., Gistri R., Petrone P., Pedemonte E., Vorgiu D., and Cecchi F. Maximum left ventricular thickness and risk of sudden death in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 41 (2003) 315-321
11. Olivotto I., Cecchi F., Casey S.A., Dolara A., Traverse J.H., and Maron B.J. Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation 104 (2001) 2517-2524
12. Maron B.J., Olivotto I., Bellone P., Conte M.R., Cecchi F., Flygenring B.P., et al. Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 29 (2002) 301-307
13. Lewis J.F., and Maron B.J. Clinical and morphologic expression of hypertrophic cardiomyopathy in patients > or = 65 years of age. Am J Cardiol 73 (1994) 1105-1111
14. Spirito P., and Maron B.J. Relation between extent of left ventricular hypertrophy and age in hypertrophic cardiomyopathy. J Am Coll Cardiol 13 (1989) 820-823
15. Fananapazir L., Tracy C.M., Leon M.B., Winkler J.B., Cannon III R.O., Bonow R.O., et al. Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy. a consecutive analysis in 155 patients. Circulation 80 (1989) 1259-1268
16. Elliott P.M., Poloniecki J., Dickie S., Sharma S., Monserrat L., Varnava A., et al. Sudden death in hypertrophic cardiomyopathy. identification of high risk patients. J Am Coll Cardiol 36 (2000) 2212-2218
17. Hakulinen T. Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics 38 (1982) 933-942
18. Maron B.J., Olivotto I., Spirito P., Casey S.A., Bellone P., Gohman T.E., et al. Epidemiology of hypertrophic cardiomyopathy-related death. revisited in a large non-referral-based patient population. Circulation 102 (2000) 858-864
19. Cecchi F., Olivotto I., Montereggi A., Santoro G., Dolara A., and Maron B.J. Hypertrophic cardiomyopathy in Tuscany. clinical course and outcome in an unselected regional population. J Am Coll Cardiol 26 (1995) 1529-1536
20. Maron B.J., Casey S.A., Poliac L.C., Gohman T.E., Almquist A.K., and Aeppli D.M. Clinical course of hypertrophic cardiomyopathy in a regional United States cohort. JAMA 281 (1999) 650-655
21. Cannan C.R., Reeder G.S., Bailey K.R., Melton III L.J., and Gersh B.J. Natural history of hypertrophic cardiomyopathy. a population-based study, 1976 through 1990. Circulation 92 (1995) 2488-2495
22. Louie E.K., and Maron B.J. Hypertrophic cardiomyopathy with extreme increase in left ventricular wall thickness. functional and morphologic features and clinical significance. J Am Coll Cardiol 8 (1986) 57-65
23. Sorajja P., Ommen S.R., Nishimura R.A., Gersh B.J., Berger P.B., and Tajik A.J. Adverse prognosis of patients with hypertrophic cardiomyopathy who have epicardial coronary artery disease. Circulation 108 (2003) 2342-2348
24. Varnava A.M., Elliott P.M., Sharma S., McKenna W.J., and Davies M.J. Hypertrophic cardiomyopathy. the interrelation of disarray, fibrosis, and small vessel disease. Heart 84 (2000) 476-482
25. Choudhury L., Mahrholdt H., Wagner A., Choi K.M., Elliott M.D., Klocke F.J., et al. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 40 (2002) 2156-2164
26. McKenna W.J., Stewart J.T., Nihoyannopoulos P., McGinty F., and Davies M.J. Hypertrophic cardiomyopathy without hypertrophy. two families with myocardial disarray in the absence of increased myocardial mass. Br Heart J 63 (1990) 287-290
27. Watkins H., McKenna W.J., Thierfelder L., Suk H.J., Anan R., O'Donoghue A., et al. Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med 332 (1995) 1058-1064
28. Ommen S.R., Maron B.J., Olivotto I., et al. Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 46 (2005) 470-476
29. Watkins H., and McKenna W.J. The prognostic impact of septal myectomy in obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 46 (2005) 470-479